Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience

Objective  The aim of the study is to describe the real-world use of the P2Y (12) inhibitor cangrelor as a bridging strategy in patients at high thrombotic risk after percutaneous coronary intervention (PCI) and referred to surgery requiring perioperative withdrawal of dual antiplatelet therapy (DAP...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:TH Open
Autors principals: Rossini, Roberta, Masiero, Giulia, Fruttero, Claudia, Passamonti, Enrico, Calvaruso, Elba, Cecconi, Moreno, Carlucci, Cesare, Mojoli, Marco, Guido, Parodi, Talanas, Giuseppe, Pierini, Simona, Canova, Paolo, De Cesare, Nicoletta, Luceri, Stefania, Barzaghi, Nicoletta, Melloni, Giulio, Baralis, Giorgio, Locatelli, Alessandro, Musumeci, Giuseppe, Angiolillo, Dominick J.
Format: Artigo
Idioma:Inglês
Publicat: Georg Thieme Verlag KG 2020
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7758156/
https://ncbi.nlm.nih.gov/pubmed/33376943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1721504
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars